CMV Study
Participants are eligible to be included in the study only if all the following criteria apply (no protocol exemptions will be allowed in this study):
- Is a female and 16 to 40 years of age, at the time of consent.
- According to the assessment of the Investigator, is in good general health and is capable of complying with study procedures.
- Has a body mass index of 15-35 kg/m2, inclusive.
- Female participants: Urine pregnancy test is negative at Screening and negative on the day of the first injection (Day 1).
- Female participants: If the participant is sexually active with men, all of the following criteria must be met:
• Has practiced adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection (Day 1).
• Agrees to continue adequate contraception through 3 months following the third study injection (Month 9/Day 257). Adequate contraception is defined as consistent and correct use of an approved contraceptive method in accordance with the product label, or sterilization of a monogamous male partner prior to study enrollment.